Prevalence of plasma small dense LDL is increased in obesity in a Thai population

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Kulanuwat, Sirikul ^a   Tungtrongchitr, Rungsunn ^a   Billington, David ^b   Davies, Ian G ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

BMI; Iodixanol; Large buoyant LDL; Obesity; Small dense LDL; Triglyceride; Ultracentrifugation

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IODIXANOL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SMALL DENSE LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ASSAY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PLASMA; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHEMISTRY; EPIDEMIOLOGY; MIDDLE AGED; PARTICLE SIZE; PREVALENCE; THAILAND;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBESITY; PARTICLE SIZE; PREVALENCE; THAILAND; TRIGLYCERIDES;

EID: 84928542045     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0034-1     Document Type: Article

References (40)

1. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359-404.
2. Vazquez G, Duval S, Jacobs Jr DR, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29:115-28.
3. Kawai M, de Paula FJ, Rosen CJ. New insights into osteoporosis: the bone-fat connection. J Intern Med. 2012;272:317-29.
4. Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301-13.
5. Strong AL, Burow ME, Gimble ME, Bunnell BA. The obesity cancer paradigm: exploration of the interactions and cross-talk with adipose stem cells. Stem Cells. 2015;33:318-26.
6. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr. 2002;11 Suppl 7:S732-7.
7. Thaikruea L, Seetamanotch W, Seetamanotch S. Appropriate cut-off level of BMI for screening in Thai adults. J Med Assoc Thai. 2006;89:2123-8.
8. Peermsuwan U, Guntawongwan K, Buddhawongsa P. Handling time in economic evaluation studies. J Med Assoc Thai. 2008;91 Suppl 2:53-8.
9. Pitayatienanan P, Butchon R, Yothasamut J, Aekplakorn W, Teerawattananon Y, Suksomboon N, et al. Economic costs of obesity in Thailand: a retrospective cost-of-illness study. BMC Health Serv Res. 2014;14:146.
10. Samsen M, Hanchaiphiboolkul S, Puthkhao P, Tantirittisak T, Towanabut S. Appropriate body mass index and waist circumference cutoffs for middle and older age group in Thailand: data of 19,621 participants from Thai epidemiologic stroke (TES) study. J Med Assoc Thai. 2012;95:1156-66.
11. Krauss RM. Low density lipoprotein subclasses and risk of coronary artery disease. Curr Opin Lipidol. 1991;2:248-52.
12. Krauss RM, Blanche PJ. Detection and quantitation of LDL subfractions. Curr Opin Lipidol. 1992;3:377-83.
13. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43:1363-79.
14. Magkos F, Mohammed BS, Mittendorfer B. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women. Int J Obes (Lond). 2008;32:1655-64.
15. Nikolic D, Katsiki N, Montalto G, Isenovic ER, Mikhailidis DP, Rizzo M. Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients. 2013;5:928-48.
16. Rizzoo M, Kotur-Stevuljevic J, Berneis K, Spinas G, Rini GB, Jelic-Ivanovic Z, et al. Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res. 2009;153:217-23.
17. Diffenderler MR, Schaefer EJ. The composition and metabolism of large and small LDL. Curr Opin Lipidol. 2014;25:221-6.
18. Mikhailidis DP, Elisaf M, Rizzo M, Bernies K, Griffin B, Zambon A, et al. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol. 2011;9:533-71.
19. Sawle A, Higgins MK, Olivant MP, Higgins JA. A rapid single-step centrifugation method for determination of HDL, LDL, and VLDL cholesterol, and TG, and identification of predominant LDL subclass. J Lipid Res. 2002;43:335-43.
20. Davies IG, Graham JM, Griffin BA. Rapid separation of LDL subclasses by iodixanol gradient ultracentrifugation. Clin Chem. 2003;49:1865-72.
21. Hirayama S, Miida T. Small sense LDL: an emerging risk factor for cardiovascular disease. Clin Chim Acta. 2012;414:215-24.
22. Yee MS, Pavitt DV, Tan T, Venkatesan S, Godsland IF, Richmond W, et al. Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis. J Lipid Res. 2008;49:1364-71.
23. Hirano T, Ito Y, Saegusa H, Yoshino G. A novel and simple method for quantification of small dense LDL. J Lipid Res. 2003;44:2193-201.
24. Ito Y, Fujimura M, Ohta M, Hirano T. Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem. 2011;57:57-65.
25. Fukushima Y, Hirayama S, Ueno T, Dohi T, Miyazaki T, Ohmura H, et al. Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome. Clin Chim Acta. 2011;412:1423-7.
26. Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, et al. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density-lipoprotein cholesterol levels. Am J Cardiol. 2008;101:315-8.
27. Nozue T, Michishita I, Ito Y, Hirano T. Effects of statin on small dense low-density-lipoprotein cholesterol and remnat-like particle cholesterol in heterozygous familial hypercholesterolemia. J Atherscler Thromb. 2008;15:146-53.
28. Tokuna A, Hirano T, Hayashi T, Mori Y, Yamamoto T, Nagashima M, et al. The effects of statin and fibrate on lowering small dense LDL cholesterol in hyperlipidemic patients with Type 2 diabetes. J Atherscler Thromb. 2007;14:128-32.
29. Winkler K, Jacob S, Müller-Schewe T, Hoffmann MM, Konrad T. Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus. Atherosclerosis. 2012;220:189-93.
30. Geiss HC, Bremer S, Barrett FHR, Otto C, Parhoefer KG. In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis. J Lipid Res. 2004;45:1459-67.
31. MacLean PS, Bower JF, Vadlamudi S, Green T, Barakat HA. Lipoprotein subpopulation distributions in lean, obese and type 2 diabetic women: a comparison of African and white Americans. Obes Res. 2000;8:62-70.
32. Bioletto S, Golay A, Munger R, Kalix B, James RW. Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. Am J Clin Nutr. 2000;71:443-9.
33. Kim S, Lee H, Lee DC, Lee HS, Lee JW. Predominance of small dense LDL differentiates metabolically unhealthy from metaboloically healthy overweight adults in Korea. Metabolism. 2014;63:415-21.
34. Aekplakorn W, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, Putwatana P, Sritara P, et al. Prevalence of dyslipidemia and management in the Thai Population, National Health Examination Survey IV, 2009. J Lipids. 2014;2014:249584.
35. Wilson PWF, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. Arterioscler Thromb Vasc Biol. 1988;8:737-41.
36. Shin HJ, Cho E, Lee HJ, Fung TT, Rimm E, Rosner B, et al. Instant noodle intake and dietary patterns are associated with distinct cardiometabolic risk factors in Korea. J Nutr. 2014;144:1247-55.
37. Fan X, Liu EY, Hoffman VP, Potts AJ, Sharma B, Henderson DC. Triglyceride/high-density lipoprotein cholesterol ratio: a surrogate to predict insulin resistance and low-density lipoprotein cholesteral particle size in nondiabetic patients with schizophrenia. J Clin Psychiatry. 2011;72:806-12.
38. Nicholls SJ, Tuzcu EM, Wolski MPH, Bayturan O, Lavoie A, Uno K, et al. Lowering the triglyceride/high-density lipopreotein cholesterol ratio is associated with the benefical impact of pioglitazone on progression of coronary athersclerosis in diabetic patients. J Am Coll Cardiol. 2011;57:153-9.
39. Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of herat disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med. 2014;62:345-9.
40. Kulanuwat S, Phonrat B, Tungtrongchitr A, Limwongse C, Chongviriyaphan N, Tungtrongchitr R, et al. Effects of PCSK1 genetic variants on obesity among Thai children and their family members: in relation to health risk, and biochemical and anthropometric parameters. Southeast Asian J Trop Med Public Health. 2014;45:214-25.